- Home
- APLT vs SWVL Comparison
APLT vs SWVL Comparison
Compare APLT & SWVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- SWVL
- Stock Information
- Founded
- APLT 2016
- SWVL 2017
- Country
- APLT United States
- SWVL United Arab Emirates
- Employees
- APLT N/A
- SWVL N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- SWVL Business Services
- Sector
- APLT Health Care
- SWVL Consumer Discretionary
- Exchange
- APLT Nasdaq
- SWVL Nasdaq
- Market Cap
- APLT 44.0M
- SWVL 44.5M
- IPO Year
- APLT 2019
- SWVL N/A
- Fundamental
- Price
- APLT $0.39
- SWVL $4.21
- Analyst Decision
- APLT Buy
- SWVL
- Analyst Count
- APLT 7
- SWVL 0
- Target Price
- APLT $6.10
- SWVL N/A
- AVG Volume (30 Days)
- APLT 2.5M
- SWVL 19.5K
- Earning Date
- APLT 08-06-2025
- SWVL 07-15-2025
- Dividend Yield
- APLT N/A
- SWVL N/A
- EPS Growth
- APLT N/A
- SWVL N/A
- EPS
- APLT N/A
- SWVL N/A
- Revenue
- APLT $265,000.00
- SWVL $17,207,362.00
- Revenue This Year
- APLT $1,768.13
- SWVL N/A
- Revenue Next Year
- APLT $292.85
- SWVL N/A
- P/E Ratio
- APLT N/A
- SWVL N/A
- Revenue Growth
- APLT N/A
- SWVL N/A
- 52 Week Low
- APLT $0.30
- SWVL $2.40
- 52 Week High
- APLT $10.62
- SWVL $8.05
- Technical
- Relative Strength Index (RSI)
- APLT 51.68
- SWVL 45.49
- Support Level
- APLT $0.32
- SWVL $3.87
- Resistance Level
- APLT $0.36
- SWVL $4.29
- Average True Range (ATR)
- APLT 0.03
- SWVL 0.45
- MACD
- APLT 0.00
- SWVL -0.03
- Stochastic Oscillator
- APLT 73.78
- SWVL 41.24
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.